Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions
US9072750B2 · kind B2 · utility
2Cited by
17References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2010 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | May 31, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/216
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a composition for use in treating corneal and conjunctival lesions, wherein the composition comprises a prostaglandin F2alpha or analogue, in a therapeutic amount, said composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative; the invention also relates to a method for treating surface ocular conditions in a patient in need thereof, comprising administering a composition of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.